NOS2 and melanoma: Moreover, iNOS knockdown caused more significant proliferative inhibition in melanoma cells mediated by the two compounds co-treatment, suggesting that inhibition of iNOS signaling at least partially contributed to the sensitization potential of melatonin in vemurafenib-mediated cell proliferation inhibition in melanoma cells.